InvestorsHub Logo
Followers 139
Posts 80604
Boards Moderated 4
Alias Born 01/22/2007

Re: locksflooring post# 96524

Tuesday, 11/24/2015 9:54:47 AM

Tuesday, November 24, 2015 9:54:47 AM

Post# of 105534
No it doesn't, not at all....

show us where it states anything that even remotely says that....

totally false, no link, no proof...

Here's the reason they sold BioCells, it's well documented in the financial filing on Edgar.

Cost of services as a percentage of revenue increased to 32% for the period ended September 30, 2013 compared to 28% the same prior period of 2012. The cost of services include transportation of the umbilical cord blood and cord tissue from the hospital to the lab, direct material plus labor costs for processing and cryogenic storage, and allocated rent, utility and general administrative expenses. Gross profit decreased by approximately $0.08 million or 7% to $1.01 million for the period ending September 30, 2013 from the prior three month period of 2012. Increases in Bio's expenses and currency adjustments were primary contributors to the reported decrease. The Company anticipates that through the growth and expansion of its Cord business, tighter cost controls and continuing efficiencies in its own facilities, direct costs should decrease and gross profits should improve.

http://www.sec.gov/Archives/edgar/data/1289496/000135448813006276/cbai_10q.htm
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.